Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for bone and vascular metabolism in osteoporotic chronic kidney disease
2016-000431-40Phase 4Completed
- Sponsor
- Health Ministry
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of denosumab in osteoporosis and chronic kidney disease (CKD) (2 arms), sponsored by Health Ministry. Primary endpoint: Relative variation of femoral bone mineral density after 24 months. Started Jun 2016; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2016-000431-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000431-40.